Milestone Pharmaceuticals Inc. Cash and Restricted Cash
Milestone Pharmaceuticals Inc. (MIST) had Cash and Restricted Cash of $71.86 million as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-05-17
- 2021-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $71.86M.
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $72.31M.
- 2020-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46.91M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $53.43M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2021-03-31 | $71.86M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $72.31M 10-Q · filed 2021-05-17 |
| 2020-09-30 | $46.91M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $53.43M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $101.82M 10-Q · filed 2021-05-17 |
| 2019-12-31 | $119.82M 10-Q · filed 2021-05-17 |
| 2019-09-30 | $106.50M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $110.82M 10-Q · filed 2020-08-12 |
| 2019-03-31 | $71.24M 10-Q · filed 2020-05-14 |
| 2018-12-31 | $85.95M 10-K · filed 2021-03-29 |
| 2018-09-30 | $4.20M 10-Q · filed 2019-11-13 |
| 2018-06-30 | $17.80M 10-Q · filed 2019-08-13 |
| 2018-03-31 | $13.18M 10-Q · filed 2019-06-19 |
| 2017-12-31 | $10.88M 10-K/A · filed 2020-10-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |